Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3463-3471

  Baral, Pankaj ^a   Utaisincharoen, Pongsak ^a  

^a Mahidol University ^*  (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARMADILLO DOMAIN PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; REGULATOR PROTEIN; SIGNAL REGULATOR PROTEIN ALPHA; SMALL INTERFERING RNA; STERILE ALPHA AND ARMADILLO MOTIF CONTAINING PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MACROPHAGE; MELIOIDOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

EID: 84884215297     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00519-13     Document Type: Article

References (47)

1. Wiersinga WJ, Currie BJ, Peacock SJ. 2012. Melioidosis. N. Engl. J. Med. 367:1035-1044.
2. Allwood EM, Devenish RJ, Prescott M, Adler B, Boyce JD. 2012. Strategies for intracellular survival of Burkholderia pseudomallei. Front. Microbiol. 2:170. doi:10.3389/fmicb.2011.00170.
3. Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD. 2009. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33:1079-1099.
4. Jones AL, Beveridge TJ, Woods DE. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
5. Harley VS, Dance DA, Drasar BS, Tovey G. 1998. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96:71-93.
6. Stevens MP, Wood MW, Taylor LA, Monaghan P, Hawes P, Jones PW, Wallis TS, Galyov EE. 2002. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol. Microbiol. 46:649-659.
7. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S. 2000. Burkholderia pseudomallei induces cell fusion and actinassociated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect. Immun. 68:5377-5384.
8. Wiersinga WJ, van der Poll T. 2009. Immunity to Burkholderia pseudomallei. Curr. Opin. Infect. Dis. 22:102-108.
9. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
10. Breitbach K, Klocke S, Tschernig T, van Rooijen N, Baumann U, Steinmetz I. 2006. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect. Immun. 74:6300-6309.
11. Arjcharoen S, Wikraiphat C, Pudla M, Limposuwan K, Woods DE, Sirisinha S, Utaisincharoen P. 2007. Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell lineRAW264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect. Immun. 75:4298-4304.
12. Wikraiphat C, Charoensap J, Utaisincharoen P, Wongratanacheewin S, Taweechaisupapong S, Woods DE, Bolscher JG, Sirisinha S. 2009. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol. Med. Microbiol. 56:253-259.
13. DeShazer D, Brett PJ, Woods DE. 1998. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 30:1081-1100.
14. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
15. Egan CE, Sukhumavasi W, Butcher BA, Denkers EY. 2009. Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii. Clin. Exp. Immunol. 156:17-24.
16. Gil ML, Gozalbo D. 2009. Role of Toll-like receptors in systemic Candida albicans infections. Front. Biosci. 14:570-582.
17. Sotolongo J, Espana C, Echeverry A, Siefker D, Altman N, Zaias J, Santaolalla R, Ruiz J, Schesser K, Adkins B, Fukuta M. 2011. Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. J. Exp. Med. 208:2705-2716.
18. Tangsudjai S, Pudla M, Limposuwan K, Woods DE, Sirisinha S, Utaisincharoen P. 2010. Involvement of the MyD88-independent pathway in controlling the intracellular fate of Burkholderia pseudomallei infection in the mouse macrophage cell line RAW 264.7. Microbiol. Immunol. 54:282-290.
19. Björkbacka H, Fitzgerald KA, Huet F, Li X, Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT, Freeman MW. 2004. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol. Genomics 19:319-330.
20. Utaisincharoen P, Anuntagool N, Limposuwan K, Chaisuriya P, Sirisinha S. 2003. Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages. Infect. Immun. 71:3053-3057.
21. Baral P, Utaisincharoen P. 2012. Involvement of signal regulatory protein alpha, a negative regulator of Toll-like receptor signaling, in impairing MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages. Infect. Immun. 80:4223-4231.
22. Pudla M, Limposuwan K, Utaisincharoen P. 2011. Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway. Infect. Immun. 79:2921-2927.
23. O'Neill LA, Fitzgerald KA, Bowie AG. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:286-290.
24. Barclay AN. 2009. Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. Curr. Opin. Immunol. 21:47-52.
25. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7:1074-1081.
26. Dong LW, Kong XN, Yan HX, Yu LX, Chen L, Yang W, Liu Q, Huang DD, Wu MC, Wang HY. 2008. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction. Mol. Immunol. 45:3025-3035.
27. Kong XN, Yan HX, Chen L, Dong LW, Yang W, Liu Q, Yu LX, Huang DD, Liu SQ, Liu H, Wu MC, Wang HY. 2007. LPS-induced downregulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages. J. Exp. Med. 204:2719-2731.
28. Kawahara K, Dejsirilert S, Danbara H, Ezaki T. 1992. Extraction and characterization of lipopolysaccharide from Pseudomonas pseudomallei. FEMS Microbiol. Lett. 75:129-133.
29. Anuntagool N, Intachote P, Wuthiekanun V, White NJ, Sirisinha S. 1998. Lipopolysaccharide from nonvirulent Ara Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara clinical isolates. Clin. Diagn. Lab. Immunol. 5:225-229.
30. Breitbach K, Wongprompitak P, Steinmetz I. 2011. Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol. 12:20. doi:10.1186/1471-2172-12-20.
31. Jeyaseelan S, Young SK, Fessler MB, Liu Y, Malcolm KC, Yamamoto M. 2007. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol. 178:3153-3160.
32. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. 2009. Both TRIFand MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183:6629-6638.
33. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. 2009. Human Toll-like receptor 4 responses to Porphyromonas gingivalis are regulated by lipid A 1-and 4'-phosphatase activities. Cell. Microbiol. 11:1587-1599.
34. Wiersinga WJ, Wieland CW, Roelofs JJ, van der Poll T. 2008. MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One 3:e3494. doi:10.1371/journal.pone.0003494.
35. West TE, Chierakul W, Chantratita N, Limmathurotsakul D, Wuthiekanun V, Emond MJ, Hawn TR, Peacock SJ, Skerrett SJ. 2012. Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis. Genes Immun. 13:38-46.
36. Wiersinga WJ, van't Veer C, van den Pangaart PS, Dondorp AM, Day NP, Peacock SJ, van der Poll T. 2009. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit. Care Med. 37:569-576.
37. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820-832.
38. Chan J, Xing Y, Magliozzo RS, Bloom BR. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
39. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
40. Nandan D, Lo R, Reiner NE. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67:4055-4063.
41. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227-236.
42. Piao W, Song C, Chen H, Diaz MA, Wahl LM, Fitzgerald KA, Li L, Medvedev AE. 2009. Endotoxin tolerance dysregulates MyD88-and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 86:863-875.
43. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. 1999. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67:3593-3600.
44. Miyagi K, Kawakami K, Saito A. 1997. Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect. Immun. 65:4108-4113.
45. Reim D, Rossmann-Bloeck T, Jusek G, Prazeres da Costa O, Holzmann B. 2011. Improved host defense against septic peritonitis in mice lacking MyD88 and TRIF is linked to a normal interferon response. J. Leukoc. Biol. 90:613-620.
46. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM, Vogel SN. 2001. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1482.
47. Kabanov DS, Prokhorenko IR. 2010. Structural analysis of lipopolysaccharides from Gram-negative bacteria. Biochemistry (Mosc) 75:383-404.